Cancer registry databases: An overview of techniques of statistical analysis and impact on cancer epidemiology

Methods in Molecular Biology

Volumn 471, Issue , 2009, Pages 31-49

  Das, Ananya ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cancer; Cancer registry; Epidemiology; SEER; SEER Medicare database

Indexed keywords

FACTUAL DATABASE; HUMAN; INCIDENCE; MASS SCREENING; NEOPLASM; PREVALENCE; REGISTER; REVIEW; STATISTICS; UNITED STATES;

DATABASES, FACTUAL; HUMANS; INCIDENCE; MASS SCREENING; NEOPLASMS; PREVALENCE; REGISTRIES; UNITED STATES;

EID: 60349089624     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-416-2_2     Document Type: Review

References (101)

1. Clive, R. E. (2004) Introduction to cancer registries, in Cancer Registry Management: Principles and Practice (Hutchison, C. L., ed.), Kendall Hunt Publishing, Dubuque, IA, pp. 1-9.
2. Parkin, D. M. (2006) The evolution of the population-based cancer registry. Nat. Rev. Cancer 6(8), 603-12.
3. Parkin, D. M., Chen, V. W., Ferlay, J., Galceran, J., Storm, H. H., and Whelan, S. L. (1994) Comparability and quality control in cancer registration, in IARC Technical Report No. 19, International Agency for Research on Cancer, Lyon, France.
4. Jensen O. M. (ed.) (1991) Cancer Registration, Principles and Methods, No. 95, International Agency for Research on Cancer, Lyon, France.
5. Working Group of the International Association of Cancer Registries (2005) Guidelines for confidentiality in population-based cancer registration. Eur J Cancer Prev 14, 309-327.
6. National Cancer Institute (2007) SEER statistical resources. http://seer.cancer.gov/resources/. Cited 4 April 2007.
7. Warren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B., and Riley, G.F. (2002) Overview of the SEER-Medicare data, content, research applications, and generalizability to the United States elderly population. Med. Care 40, 5-18.
8. Spittle, M. F. (1998) Spectrum of AIDS-associated malignant disorders. Lancet 351(9119), 1833-9.
9. Centers for Disease Control and Prevention (2007) National Center for Chronic Disease Prevention and Health Promotion. Behavioral Risk Factor Surveillance System. http://www.cdc.gov/brfss/index.htm. Cited 4 April 2007.
10. National Center for Health Statistics (2007) National Health Interview Survey. http://www.cdc.gov/nchs/nhis.htm. Cited 4 April 4 2007.
11. National Center for Health Statistics (2007) National Hospital Discharge and Ambulatory Surgery Data. http://www.cdc.gov/nchs/about/major/hdasd/nhds.htm. Cited 4 April 2007.
12. National Center for Health Statistics (2007) Ambulatory Health Care Data. http://www.cdc.gov/nchs/about/major/ahcd/ahcd1.htm. Cited 4 April 2007.
13. Harlan, L.C., and Hankey, B.F. (2003) The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies. J Clin Oncol 21(12), 2232-3.
14. Hankey, B. F., Ries, L. A., and Edwards, B. K. (1999) The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 8(12), 1117-21.
15. Centers for Disease Control and Prevention (2007) National Program of Cancer Registries. http://www.cdc.gov/cancer/npcr/about.htm. Cited 4 April 2007.
16. National Cancer Institute (2007) SEER-Medicare Linked Database. http://health-services.cancer.gov/. Cited 4 April 2007.
17. Clegg, L. X., Feuer, E. J., Midthune, D., Fay, M. P., and Hankey, B. F. (2002) Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 94, 1537-45.
18. Midthune, D. N., Fay, M. P., Clegg, L. X., and Feuer, E. J. (2005) Modeling reporting delays and reporting corrections in cancer registry data. J Am Stat Assoc 100(469), 61-70.
19. Merrill, R. M., and Feuer, E. J. (1996) Risk-adjusted cancer-incidence rates (United States). Cancer Causes Control 7(5), 544-52.
20. Fay, M. P. (2004) Estimating age conditional probability of developing disease from surveillance data. Popul Health Metr 2(1), 6.
21. Fay, M. P., Pfeiffer, R., Cronin, K. A.., Le, C., and Feuer, E. J. (2003) Age-conditional probabilities of developing cancer. Stat Med 22(11), 1837-48.
22. Kim, H. J., Fay, M. P., Feuer, E. J., and Midthune, D. N. (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19, 335-51
23. Curtis, R. E., Freedman, D. M., Ron, E., Ries, L. A. G., Hacker, D. G., Edwards, B. K., Tucker, M. A., and Fraumeni, J. F., Jr. (eds) (2006) New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. National Cancer Institute. National Institutes of Health Publ. No. 05-5302. National Institutes of Health, Bethesda, MD.
24. Schoenberg, B. S., and Myers, M. H. (1977) Statistical methods for studying multiple primary malignant neoplasms. Cancer 40, 1892-1898.
25. Begg, C. B., Zhang, Z., Sun, M., Herr, H. W., and Schantz, S. P. (1995) Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancer from the Surveillance, Epidemiology, and End Results (SEER) Program. Am J Epidemiol 142, 653-665.
26. Fay, M. P., and Feuer, E. J. (1997) Confidence intervals for directly standardized rates: a method based on the Gamma distribution. Stat Med 16, 791-801.
27. Chu, K. C., Miller, B. A., Feuer, E. J., and Hankey, B. F. (1994) A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol 47(12), 1451-61.
28. Mariotto, A., Warren, J. L., Knopf, K. B., and Feuer, E. J. (2003) The prevalence of colorectal cancer patients under care in the US. Cancer 98, 1253-61.
29. Coldman, A. J., McBride, M. L., and Braun, T. (1992) Calculating the prevalence of cancer. Stat Med 11, 1579-89.
30. Capocaccia, R., and De Angelis, R. (1997) Estimating the completeness of prevalence based on cancer registry data. Stat Med 16, 425-40.
31. Clegg, L., Gail, M., and Feuer, E. J. (2002) Estimating the variance of disease prevalence estimates from population-based registries. Biometrics 58(3) , 684-8.
32. Feldman, A. R., Kessler, L., Myers, M. H., and Naughton, M. D. (1986) The prevalence of cancer. N Engl J Med 315, 1394-7.
33. Gershman, S. T., Flannery, J. T., Barrett, H., Nadel, R. K., and Meigs, J. W. (1976) Development of the Connecticut Tumor Registry. Conn Med 40, 697-701.
34. Merrill, R. M., Feuer, E. J., Cappacaccia, R., and Mariotto, A. (2000) Cancer prevalence estimates based on tumor registry data in the SEER Program. Int J Epidemiol 29, 197-207.
35. Byrne, J., Kessler, L. G., and Devesa, S. S. (1992) The prevalence of cancer among adults in the United States. Cancer 68, 2154-9.
36. Gail, M. H., Kessler L, Midthune, D., and Scoppa S. (1999) Two approaches for estimating disease prevalence from population-based registries of incidence and total mortality. Biometrics 55, 1137-44.
37. De Angelis, G. D., De Angelis, R., Frova, L., and Verdecchia, A. (1994) MIAMOD: a computer program to estimate chronic disease morbidity using mortality and survival data. Comput Methods Programs Biomed 44, 99-107.
38. Verdecchia, A., De Angelis, G., and Capocaccia, R. (2002) Estimation and projections of cancer prevalence from cancer registry data. Stat Med 21(22), 3511-26.
39. Keiding, N. (1991) Age-specific incidence and prevalence: a statistical perspective. J R Stat Soc Ser A 154, 371-412.
40. Marubini, E., and Valsecchi, M. G (eds) (2004) Analyzing Survival Data from Clinical Trials and Observational Studies, Wiley, Hoboken, NJ.
41. Boer, R., Ries, L., van Ballegooijen, M., Feuer, E., Legler, J., and Habbema, D. (2003) Ambiguities in calculating cancer patient survival: the SEER experience for colorectal and prostate cancer. Technical Report 2003-05, Statistical Research and Applications Branch, National Cancer Institute, Bethesda, MD ( http://srab.cancer.gov/reports).
42. Brown, C.C. (1983) The statistical comparison of relative survival rates. Biometrics 39, 941-8.
43. Ederer, F., Axtell, L. M., and Cutler, S. J. (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6, 101-21.
44. Brenner, H., and Hakulinen, T. (2002) Advanced detection of time trends in long-term cancer patient survival: experience from 50 years of cancer registration in Finland. Am J Epidemiol 156(6), 566-77.
45. Yu, B., Tiwari, R. C., Cronin, K. A., McDonald, C., and Feuer, E. J. (2005) CANSURV: a Windows program for population-based cancer survival analysis. Comput Methods Programs Biomed 80(3), 195-203.
46. Yu, B., Tiwari, R. C., Cronin, K. A, and Feuer, E. J. (2004) Cure fraction estimation from the mixture cure models for grouped survival data. Stat Med 23(11), 1733-47.
47. Brewer, C. A. (2006) Basic mapping principles for visualizing cancer data using geographic information systems (GIS). Am J Prev Med 30(2 Suppl), S25-S36.
48. Bell, B. S, Hoskins, R. E., Pickle, L. W., and Wartenberg, D. (2006) Current practices in spatial analysis of cancer data: mapping health statistics to inform policymakers and the public. Int J Health Geogr 8, 5:49.
49. Pickle, L. W., Hao, Y., Jemal, A., Zou, Z, Tiwari, R. C., and Ward, E., et al. (2007) A new method of estimating United States and state-level cancer incidence counts for the current calendar year. CA Cancer J Clin 57, 30-42.
50. National Cancer Institute (2006) SEER*Stat software, version 6.2. Statistical Research and Applications Branch, National Cancer Institute. http://seer.cancer.gov/seerstat/. Cited 4 April 2007.
51. National Cancer Institute (2006) SEER*Prep software, version 2.3.5. Statistical Research and Applications Branch, National Cancer Institute. http://srab.cancer.gov/seerprep/. Cited 4 April 2007.
52. National Cancer Institute (2006) DevCan 6.1.1 for Windows software, version 6.1.1. Statistical Research and Applications Branch, National Cancer Institute. http://srab.cancer.gov/devcan/. Cited 4 April 2007.
53. National Cancer Institute (2006) Joinpoint regression program, version 3.0. Statistical Research and Applications Branch, National Cancer Institute. http://srab.cancer.gov/joinpoint/. Cited 4 April 2007.
54. National Cancer Institute (2006) Complete Prevalence (ComPrev) software, version 1.0. Statistical Research and Applications Branch, National Cancer Institute. http://srab.cancer.gov/comprev/. Cited 4 April 2007.
55. National Cancer Institute (2006) Projected Prevalence (ProjPrev) software, version 1.0.1. Statistical Research and Applications Branch, National Cancer Institute. http://srab.cancer.gov/projprev/. Cited 4 April 2007.
56. National Cancer Institute (2006) CanSurv software, version 1. Statistical Research and Applications Branch, National Cancer Institute. http://srab.cancer.gov/cansurv/. Cited 4 April 2007.
57. National Cancer Institute (2006) Head-Bang PC software, version 3.0. Hansen; Simonson and Statistical Research and Applications Branch, National Cancer Institute. http://srab.cancer.gov/headbang/. Cited 4 April 2007.
58. Kulldorff, M. and Information Management Services, Inc. (2007) SaTScan™ version 7.0: software for the spatial and space-time scan statistics. http://www.satscan.org/. Cited 4 April 2007.
59. National Cancer Institute (200X) State cancer profiles. http://statecancerprofiles.cancer.gov/index.html/. Cited 4 April 2007.
60. North American Association of Central Cancer Registries (200X) CINA + Online Cancer in North America. http://www.cancer-rates.info/naaccr/. Cited 4 April 2007.
61. Ferlay, J., Bray, F., Pisani, P., and Parkin, D. M. (2004) GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5. Version 2.0. IARC Press, Lyon, France. ( http://www-dep.iarc.fr/).
62. Glaser, S. L., Clarke, C. A., Gomez, S. L., O'Malley, C. D., Purdie, D. M., and West, D. W. (2005) Cancer surveillance research, a vital subdiscipline of cancer epidemiology. Cancer Causes Control 16, 1009-1019.
63. Clemmesen, J. (1948) Carcinoma of the breast. Results from statistical research (symposium). Br J Radiol 21, 583-590.
64. Buell, P., and Dunn, J. E., Jr. (1965) Cancer mortality among Japanese Issei and Nisei of California. Cancer 18, 656-64.
65. Alavanja, M. C., Sandler, D. P., McMaster, S. B., Zahm, S. H., McDonnell, C. J., and Lynch, C. F., et al. (1996) The Agricultural Health Study. Environ Health Perspect 104 (4), 362-369.
66. Silverman, D. T., Hartge, P., Morrison, A. S., and Devesa, S. S. (1992) Epidemiology of bladder cancer. Hematol Oncol Clin North Am 6(1), 1-30.
67. National Cancer Institute Health (1999) Effects of Exposure to Environmental Tobacco Smoke, Smoking and Tobacco Control Monograph No. 10. U.S. Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD.
68. No authors listed (1986) Oral contraceptive use and risk of breast cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. N Engl J Med 315, 405-411.
69. Le Marchand, L., Yoshizawa, C. N., Kolonel, L. K., Hankin, J. H., and Goodman, M. T. (1989) Vegetable consumption and lung cancer risk: a population-based case-control study in Hawaii. J Natl Cancer Inst 81, 1158-1164.
70. Irwin, M. L., Aiello, E.J., McTiernan, A., Bernstein, L., Gilliland, F. D., Baumgartner, R. N., et al. (2007) Physical activity, body mass index, and mammographic density in postmenopausal breast cancer survivors. J Clin Oncol 25(9), 1061-6.
71. Cerhan, J. R., Anderson, K. E., Janney, C. A., Vachon, C. M., Witzig, T. E., and Habermann, T. M. (2003) Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int J Cancer 106(5), 784-8.
72. Kleinerman, R. A., Boice, J. D., Jr., Storm, H. H., Sparen, P., Andersen, A., Pukkala, E., Lynch, C. F., et al. (1995) Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer 76, 442-452.
73. Travis, L. B., Curtis, R. E., Storm, H., Hall, P., Holowaty, E., Van Leeuwen, F. E., et al. (1997) Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 89, 1429-1439.
74. Travis, L. B., Gospodarowicz, M., Curtis, R. E., Clarke, E.A., Andersson, M., Glimelius, B., et al. (2002) Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 94, 182-192.
75. Zablotska, L. B., Chak, A., Das, A., and Neugut, A.I. (2005) Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer. Am J Epidemiol 161(4), 330-7.
76. Das, A., Neugut, A. I., Cooper, G. S., and Chak, A. (2004) Association of ampullary and colorectal malignancies. Cancer 100(3), 524-30.
77. Brewster, D. H, Fordyce, A., and Black, R. J. (2004) Scottish clinical geneticists. Impact of a cancer registry-based genealogy service to support clinical genetics services. Fam Cancer 3(2), 139-41.
78. Ziogas, A., and Anton-Culver, H. (2003) Validation of family history data in cancer family registries. Am J Prev Med 24(2), 190-198.
79. Bernstein, J. L., Langholz, B. M., Haile, R.W., Bernstein, L., Thomas, D. C., and Stovall, M., et al. (2004) Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE Study. Breast Cancer Res 6, R199-R214
80. Blot, W. J., Devesa, S. S., Kneller, R. W., and Fraumeni, J. F., Jr. (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265, 1287-1289.
81. Reynolds, P., Layefsky, M. E., Saunders, L. D, George, F. L., and Payne, S. F. (1990) Kaposi's sarcoma reporting in San Francisco: comparison of AIDS and cancer surveillance systems. J Acquir Immune Defic Syndr 3(Suppl 1), S8-S13.
82. Blumenstock, J., Fagliano, J., and Bresnitz, E. (2000) The Dover Township childhood cancer investigation. N J Med 97, 25-30.
83. Roche, L. M., Skinner, R., and Weinstein, R. B. (2002) Use of a geographic information system to identify and characterize areas with high proportions of distant stage breast cancer. J Public Health Manag Pract 8, 26-32.
84. Giordano, S. H., Cohen, D. S., Buzdar, A. U., Perkins, G., and Hortobagyi, G. N. (2004) Breast carcinoma in men: a population-based study. Cancer 101(1), 51-7.
85. Swan, J., and Edwards, B. K. (2003) Cancer rates among American Indians and Alaska Natives: is there a national perspective. Cancer 98(6), 1262-72
86. Gail, M. H., Brinton, L. A., Byar, D. P, Corle, D. K., Green, S. B., Schairer, C., et al. (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81, 1879-1886.
87. Feuer, E. J., Wun, L. M., Boring, C. C., Flanders, W. D., Timmel, M. J., and Tong, T. (1993) The lifetime risk of developing breast cancer. J Natl Cancer Inst 85, 892-897.
88. Harper, S., and Lynch, J. (2005) Methods for measuring cancer disparities: using data relevant to healthy people 2010 cancer-related objectives. NCI Cancer Surveillance Monograph Series, No. 6. National Cancer Institute, Bethesda, MD.
89. Humble, C. G., Samet, J. M., Pathak, D. R., and Skipper, B. J. (1985) Cigarette smoking and lung cancer in 'Hispanic' whites and other whites in New Mexico. Am J Public Health 75(2), 145-148.
90. Chen, V. W., Fontham, E. T. H., Craig, J. F., Groves, F. D., Culley, P., Rainey, J. M., et al. (1992) Cancer in South Louisiana. Part I: tobacco-related cancers. J La Med Soc 144, 149-155.
91. Friedell, G. H., Tucker, T. C., McManmon, E., Moser, M., Hernandez, C., and Nadel, M. (1992) Incidence of dysplasia and carcinoma of the uterine cervix in an Appalachian population. J Natl Cancer Inst 84, 1030-1032.
92. Chen, V. W., Wu, X. C., Andrews, P. A., Fontham, E. T., and Correa, P. (1994) Advanced stage at diagnosis: an explanation for higher than expected cancer death rates in Louisiana? J La Med Soc 146, 137-145.
93. Mills, P. K., and Kwong, S. (2001) Cancer incidence in the united farm workers of America (UFW) 1987-1997. Am J Ind Med 40, 596-603.
94. Barnoya, J., and Glantz, S. (2004) Association of the California tobacco control program with declines in lung cancer incidence. Cancer Causes Control 15(7), 689-95.
95. Harlan, L. C., Abrams, J., Warren, J. L., Clegg, L., Stevens, J., and Ballard-Barbash, R. (200) Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncol 20, 1809-1817.
96. Potosky, A. L., Harlan, L. C., Kaplan, R. S., Johnson, K. A., and Lynch, C. F. (2002) Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20, 1192-1202.
97. Harlan, L. C., Clegg, L. X., and Trimble, E. L. (2003) Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the U.S. J Clin Oncol 21(18), 3488-94
98. Potosky, A. L., Riley, G. F., Lubitz, J. D., Mentnech, R. M., and Kessler, L. G. (1993) Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31(8), 732-748.
99. Brown, M. L., Riley, G. F., Schussler, N., and Etzioni, R. (2002) Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 40(8 Suppl IV), 104-17.
100. Doebbeling, B. N., Wyant, D. K., McCoy, K. D., Riggs, S., Woolson, R. F., Wagner, D., et al. (1999) Linked insurance-tumor registry database for health services research. Med Care 37(11), 1105-15.
101. McClish, D. K., Penberthy, L., Whittemore, M., Newschaffer, C., Woolard, D., Desch, C. E., et al. (1997) Ability of Medicare claims data and cancer registries to identify cancer cases and treatment. Am J Epidemiol 145(3), 227-33.